This Tesla Analyst Must Be On ‘Hallucinogenic Drugs,’ Says Value Investor In Response To Morgan Stanley’s Value Proposition – Tesla (NASDAQ:TSLA)
[ad_1] As Tesla Inc TSLA shares continued to slip toward Morgan Stanley’s bear case, analyst Adam Jonas started to wonder if Tesla was leaning into value territory. A member of CNBC’s “Halftime Report”…